Tokyo Tape
Sign in
← Medipal Holdings

Quarterly report · Q1

7459.TEDINET S100OYEC
Period2022-04-01 → 2022-06-30
Filed2022-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥838.3bn2022-04-01 → 2022-06-30Cons.Net sales
Revenue¥3.29T2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥824.9bn2021-04-01 → 2021-06-30Cons.Net sales
Operating income¥13.5bn2022-04-01 → 2022-06-30Cons.Operating income
Operating income¥13.3bn2021-04-01 → 2021-06-30Cons.Operating income
Ordinary income¥17.6bn2022-04-01 → 2022-06-30Cons.Ordinary income
Ordinary income¥62.0bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥17.4bn2021-04-01 → 2021-06-30Cons.Ordinary income
Profit before tax¥17.2bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Profit before tax¥17.5bn2021-04-01 → 2021-06-30Cons.Income before income taxes
Net income (owners)¥8.3bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥29.4bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥9.4bn2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent
Net income¥10.8bn2022-04-01 → 2022-06-30Cons.Profit loss
Net income¥12.2bn2021-04-01 → 2021-06-30Cons.Profit loss
Total assets¥1.72Tat 2022-06-30Cons.Assets
Total assets¥1.71Tat 2022-03-31Cons.Assets
Total assets¥1.70Tat 2021-06-30Cons.Total assets (5-year summary)
Total liabilities¥1.06Tat 2022-06-30Cons.Liabilities
Total liabilities¥1.06Tat 2022-03-31Cons.Liabilities
Net assets / equity¥659.0bnat 2022-06-30Cons.Net assets
Net assets / equity¥649.1bnat 2022-03-31Cons.Net assets
Net assets / equity¥645.5bnat 2021-06-30Cons.Net assets (5-year summary)
Cash and deposits¥218.8bnat 2022-06-30Cons.Cash and deposits
Cash and deposits¥243.2bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥39.392022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥140.142021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥44.992021-04-01 → 2021-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥36.942022-04-01 → 2022-06-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥131.412021-04-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥42.222021-04-01 → 2021-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio31.4%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio31.0%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio31.1%at 2021-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥913m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥913m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30¥98m
jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentrevenue2022-04-01 → 2022-06-30¥18.5bn
jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentrevenue external2022-04-01 → 2022-06-30¥18.5bn
jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥1m
jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentsegment profit2022-04-01 → 2022-06-30¥692m
jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentrevenue2022-04-01 → 2022-06-30¥276.2bn
jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentrevenue external2022-04-01 → 2022-06-30¥276.2bn
jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥94m
jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentsegment profit2022-04-01 → 2022-06-30¥6.5bn
jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue2022-04-01 → 2022-06-30¥544.4bn
jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue external2022-04-01 → 2022-06-30¥543.6bn
jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥817m
jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentsegment profit2022-04-01 → 2022-06-30¥6.2bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-06-30¥839.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-06-30¥838.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-06-30¥913m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥13.4bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-06-30−¥937m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-06-30−¥937m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-06-30¥169m
jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentrevenue2021-04-01 → 2021-06-30¥18.1bn
jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentrevenue external2021-04-01 → 2021-06-30¥18.1bn
jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥0
jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segmentsegment profit2021-04-01 → 2021-06-30¥734m
jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentrevenue2021-04-01 → 2021-06-30¥269.7bn
jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentrevenue external2021-04-01 → 2021-06-30¥269.6bn
jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥90m
jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segmentsegment profit2021-04-01 → 2021-06-30¥7.0bn
jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue2021-04-01 → 2021-06-30¥538.0bn
jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue external2021-04-01 → 2021-06-30¥537.1bn
jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥846m
jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segmentsegment profit2021-04-01 → 2021-06-30¥5.4bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-06-30¥825.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-06-30¥824.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-06-30¥937m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-06-30¥13.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 379
ItemContextValueUnit
Provision for bonusesCurrentQuarterInstant4044000000JPY
Provision for loss on disaster clPrior1YearInstant497000000JPY
Provision for loss on disaster clCurrentQuarterInstant286000000JPY
Provision for loss on anti monopoly act clPrior1YearInstant3479000000JPY
Provision for loss on anti monopoly act clCurrentQuarterInstant3479000000JPY
Other clPrior1YearInstant45881000000JPY
Other clCurrentQuarterInstant44644000000JPY
Current liabilitiesPrior1YearInstant1008816000000JPY
Current liabilitiesCurrentQuarterInstant1005260000000JPY
Net defined benefit liabilityPrior1YearInstant16401000000JPY
Net defined benefit liabilityCurrentQuarterInstant16450000000JPY
Other nclPrior1YearInstant35166000000JPY
Other nclCurrentQuarterInstant36603000000JPY
Noncurrent liabilitiesPrior1YearInstant51568000000JPY
Noncurrent liabilitiesCurrentQuarterInstant53054000000JPY
LiabilitiesPrior1YearInstant1060384000000JPY
LiabilitiesCurrentQuarterInstant1058314000000JPY
Capital stockPrior1YearInstant22398000000JPY
Capital stockCurrentQuarterInstant22398000000JPY
Capital surplusPrior1YearInstant133922000000JPY
Capital surplusCurrentQuarterInstant133922000000JPY
Retained earningsPrior1YearInstant385611000000JPY
Retained earningsCurrentQuarterInstant389052000000JPY
Treasury stockPrior1YearInstant-58612000000JPY
Treasury stockCurrentQuarterInstant-58612000000JPY
Shareholders equityPrior1YearInstant483320000000JPY
Shareholders equityCurrentQuarterInstant486761000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant58956000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant63749000000JPY
Deferred gains or losses on hedgesPrior1YearInstant5000000JPY
Deferred gains or losses on hedgesCurrentQuarterInstant41000000JPY
Revaluation reserve for landPrior1YearInstant-13737000000JPY
Revaluation reserve for landCurrentQuarterInstant-13737000000JPY
Foreign currency translation adjustmentPrior1YearInstant1178000000JPY
Foreign currency translation adjustmentCurrentQuarterInstant1642000000JPY
Remeasurements of defined benefit plansPrior1YearInstant580000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant460000000JPY
Valuation and translation adjustmentsPrior1YearInstant46984000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant52155000000JPY
Non controlling interestsPrior1YearInstant118784000000JPY
Non controlling interestsCurrentQuarterInstant120123000000JPY
Net assetsPrior1YearInstant649089000000JPY
Net assetsCurrentQuarterInstant659040000000JPY
Liabilities and net assetsPrior1YearInstant1709474000000JPY
Liabilities and net assetsCurrentQuarterInstant1717354000000JPY
Net salesPrior1YTDDuration824877000000JPY
Net salesCurrentYTDDuration838328000000JPY
Cost of salesPrior1YTDDuration769821000000JPY
Cost of salesCurrentYTDDuration782302000000JPY
Gross profitPrior1YTDDuration55055000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass